Investor Presentation
Attractive market fundamentals | Leadership and scale | Multiple growth drivers | Margin improvement | Attractive financial outlook | Compelling sustainability story
Attractive and growing market with
increasing share in Biosimilars
Off-patent market¹
Gross sales, in USD bn
208
23
185
2022
Generics
Biosimilars
Key drivers
420
CAGR
'22-'31
Supportive demographic trends
+8%
122
+20%
Challenged healthcare systems
Growing value of loss
of exclusivity
298
+5%
2031
1. Based on Company analysis using IQVIA Analytics Link MAT12-2022 data in LCUSD at gross price, excludes certain sizeable markets with no or limited
Sandoz operations; 2022-2031 CAGR for Biocomparable, Early Entry Generics and Generics as defined by IQVIA and includes all ATC and NFC forms
9
Management Presentation
Shifting share towards Biosimilars
Increasing market adoption of
Generics and Biosimilars
SANDOZView entire presentation